Gough A, Chapman S, Wagstaff K, Emery P, Elias E
Department of Rheumatology, Harrogate District Hospital.
BMJ. 1996 Jan 20;312(7024):169-72. doi: 10.1136/bmj.312.7024.169.
Monocycline is the most widely prescribed systemic antibiotic for acne largely because it needs to be given only once or twice a day and seems not to induce resistance. Up to April 1994 11 cases of minocycline induced systemic lupus erythematosus and 16 cases of hepatitis had been reported to the Committee on Safety of Medicines. An analysis of these cases together with seven other cases shows the severity of some of these reactions. Two patients died while taking the drug for acne and a further patient needed a liver transplant. Acne itself can induce arthritis and is often seen in association with autoimmine liver disease, but the clinical and biochemical resolution seen after withdrawal of the drug, despite deterioration of the acne, suggests a drug reaction. In five cases re-exposure led to recurrence. Because reactions may be severe early recognition is important to aid recovery and also to avoid invasive investigations and treatments such as corticosteroids and immunosuppresants. Safer alternatives should be considered for treating acne.
米诺环素是治疗痤疮最常用的全身性抗生素,主要是因为它每天只需服用一到两次,而且似乎不会产生耐药性。截至1994年4月,药品安全委员会已收到11例米诺环素诱发系统性红斑狼疮的报告和16例肝炎报告。对这些病例以及其他7例病例的分析显示了其中一些反应的严重性。两名患者在服用该药治疗痤疮时死亡,另有一名患者需要进行肝移植。痤疮本身可诱发关节炎,且常与自身免疫性肝病相关,但停药后临床和生化指标恢复正常,尽管痤疮病情恶化,提示为药物反应。5例再次用药后复发。由于反应可能很严重,早期识别对于帮助康复以及避免进行侵入性检查和治疗(如使用皮质类固醇和免疫抑制剂)很重要。治疗痤疮应考虑使用更安全的替代药物。